The rise of deep-cold storage drugs: Challenges and solutions with glass vials
mRNA. saRNA. DNA drugs. Only some groundbreaking medical developments that offer new possibilities for treating different diseases. The stability of these biological drugs, until they are injected, is mainly achieved with storage at deep-cold temperatures. This brings several significant challenges for pharmaceutical companies.
This Pharmaversity® session will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape.
This Pharmaversity® session will explore the complexities of deep-cold requirements and unveil a novel glass solution – EVERIC® freeze. As the first glass vial with optimized strength for applications down to -80°C, EVERIC® freeze promises to redefine the biological drug storage landscape.
